Primary pulmonary hypertension : report on a WHO meeting, pp.15-17, 1973. ,
Report of an expert committee, World Health Organ Tech Rep Ser, vol.213, p.35, 1961. ,
ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), Eur Heart J. 1 janv, vol.37, issue.1, pp.67-119, 2015. ,
Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J. janv, vol.53, issue.1, 2019. ,
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review, Eur Respir J, vol.34, issue.4, pp.888-94, 2009. ,
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis, Eur Respir J, vol.51, issue.4, 2018. ,
Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality, Am J Respir Crit Care Med, vol.15, issue.4, pp.509-525, 2018. ,
Pulmonary hypertension due to left heart disease, Eur Respir J. janv, vol.53, issue.1, 2019. ,
,
, Pulmonary hypertension due to left heart diseases, J Am Coll Cardiol. 24 déc, vol.62, pp.100-108, 1925.
Epidemiology and treatment of pulmonary arterial hypertension, Nature Reviews Cardiology, vol.14, issue.10, pp.603-617, 2017. ,
Pulmonary arterial hypertension in France: results from a national registry, Am J Respir Crit Care Med. 1 mai, vol.173, issue.9, pp.1023-1053, 2006. ,
Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry, Chest. févr, vol.137, issue.2, pp.376-87, 2010. ,
A USA-based registry for pulmonary arterial hypertension: 1982-2006, Eur Respir J. déc, vol.30, issue.6, pp.1103-1113, 2007. ,
An epidemiological study of pulmonary arterial hypertension, Eur Respir J. juill, vol.30, issue.1, pp.104-113, 2007. ,
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland, Am J Respir Crit Care Med, vol.186, issue.8, pp.790-796, 2012. ,
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry, Ann Intern Med. 1 sept, vol.115, issue.5, pp.343-352, 1991. ,
Primary pulmonary hypertension. A national prospective study, Ann Intern Med. août, vol.107, issue.2, pp.216-239, 1987. ,
,
Survival in pulmonary hypertension in Spain: insights from the Spanish registry, Eur Respir J. sept, vol.40, issue.3, pp.596-603, 2012. ,
Treatment of pulmonary arterial hypertension, N Engl J Med, vol.351, issue.14, pp.1425-1461, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-01455600
Risk stratification and medical therapy of pulmonary arterial hypertension, Eur Respir J. janv, vol.53, issue.1, 2019. ,
Initial dual oral combination therapy in pulmonary arterial hypertension, Eur Respir J, vol.47, issue.6, pp.1727-1763, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01301539
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging. mars, vol.16, issue.3, pp.233-70, 2015. ,
Right Ventricular Afterload Sensitivity Has Been on My Mind. Circ Heart Fail, vol.12, p.6345, 2019. ,
Pinsino A. Feasibility and usefulness of non-invasive hemodynamic monitoring in evaluating the response to intravenous therapy in decompensated heart failure, Eur Respir J. févr, vol.39, issue.2, pp.253-62, 1957. ,
The endothelium in hypoxic pulmonary vasoconstriction, J Appl Physiol, vol.01, issue.6, pp.1635-1681, 2017. ,
Physiology and pathophysiology of pulmonary circulation ,
, Microcirc Endothelium Lymphatics, vol.6, pp.211-52, 1990.
Physiology of the pulmonary circulation and the right heart, Curr Hypertens Rep. déc, vol.15, issue.6, pp.623-654, 2013. ,
Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev. juin, vol.43, issue.2, pp.109-151, 1991. ,
The L-arginine-nitric oxide pathway, N Engl J Med. 30 déc, vol.329, issue.27, pp.2002-2014, 1993. ,
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension, N Engl J Med. 17 juin, vol.328, issue.24, pp.1732-1741, 1993. ,
Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia, Circulation. 21 août, vol.116, issue.8, pp.936-979, 2007. ,
cGMP signal termination, Biochem Soc Trans. nov, vol.24, issue.4, pp.1019-1041, 1996. ,
Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension, Eur Respir Rev. déc, vol.24, issue.138, pp.630-671, 2015. ,
Role of prostacyclin in pulmonary hypertension, Glob Cardiol Sci Pract, vol.2014, issue.4, pp.382-93, 2014. ,
Endothelial cells in culture produce a vasoconstrictor substance, J Cell Physiol. août, vol.132, issue.2, pp.263-70, 1987. ,
Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction, Scand Cardiovasc J Suppl, vol.46, pp.1-40, 1997. ,
The role of endothelin system in cardiovascular disease and the potential therapeutic perspectives of its inhibition, Curr Top Med Chem, vol.13, issue.2, pp.95-114, 2013. ,
Evaluation of endothelin-1-induced pulmonary vasoconstriction following myocardial infarction, Exp Biol Med (Maywood). juin, vol.231, issue.6, pp.840-846, 2006. ,
Role of endothelin in the increased vascular tone of patients with essential hypertension, Hypertension. févr, vol.33, issue.2, pp.753-761, 1999. ,
Endothelin receptor antagonists, Handb Exp Pharmacol, vol.218, pp.199-227, 2013. ,
Nitric oxide/cyclic GMP pathway mediates the endothelin-1-upregulation of adiponectin expression in rat cardiomyocytes, Biomed Rep. sept, vol.7, issue.3, pp.267-71, 2017. ,
Mechanisms of disease: pulmonary arterial hypertension, Nat Rev Cardiol. 21 juin, vol.8, issue.8, pp.443-55, 2011. ,
,
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension, Am J Respir Crit Care Med. 1 août, vol.186, issue.3, pp.81-85, 2000. ,
Pulmonary venoocclusive disease, Eur Respir J, vol.47, issue.5, pp.1518-1552, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02561102
TBX4 mutations (small patella syndrome) are associated with childhoodonset pulmonary arterial hypertension, J Med Genet. août, vol.50, issue.8, pp.500-506, 2013. ,
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology, J Am Coll Cardiol. 24 déc, vol.62, pp.22-33, 1925. ,
Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update, Eur Respir J, vol.53, issue.1, 2019. ,
The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension, J Am Coll Cardiol. 17 janv, vol.69, issue.2, pp.236-279, 2017. ,
Diagnosis of pulmonary hypertension, Eur Respir J. janv, vol.53, issue.1, 2019. ,
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers, J Am Coll Cardiol. 19 déc, vol.46, issue.3, pp.2546-52, 2006. ,
Sildenafil citrate therapy for pulmonary arterial hypertension, N Engl J Med, vol.17, issue.20, pp.2148-57, 2005. ,
,
, Tadalafil therapy for pulmonary arterial hypertension, Circulation. 9 juin, vol.119, issue.22, pp.2894-903, 2009.
,
, Riociguat for the treatment of pulmonary arterial hypertension, N Engl J Med. 25 juill, vol.369, issue.4, pp.330-370, 2013.
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial, Ann Intern Med, vol.149, issue.8, pp.521-551, 2008. ,
,
, Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension, N Engl J Med. 27 août, vol.373, issue.9, pp.834-878, 2015.
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study, Eur Respir J. juin, vol.43, issue.6, pp.1691-1698, 2014. ,
Bosentan therapy for pulmonary arterial hypertension, N Engl J Med. 21 mars, vol.346, issue.12, pp.896-903, 2002. ,
Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2, Circulation. 10 juin, vol.117, issue.23, pp.3010-3019, 2008. ,
,
, Macitentan and morbidity and mortality in pulmonary arterial hypertension, N Engl J Med. 29 août, vol.369, issue.9, pp.809-827, 2013.
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: realworld insights, Eur Respir J. août, vol.46, issue.2, pp.414-435, 2015. ,
,
, Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension, Eur Respir J. août, vol.46, issue.2, pp.405-418, 2015.
Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol), Ann Intern Med. 1 avr, vol.112, issue.7, pp.485-91, 1990. ,
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial, Ann Intern Med. 21 mars, vol.334, issue.5, pp.425-459, 1996. ,
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial, Am J Respir Crit Care Med. 15 mars, vol.165, issue.6, pp.800-804, 2002. ,
Selexipag for the Treatment of Pulmonary Arterial Hypertension, N Engl J Med. 24 déc, vol.373, issue.26, pp.2522-2555, 2015. ,
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial, J Am Coll Cardiol, vol.55, issue.18, pp.1915-1937, 2010. ,
Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension, CHEST. 1 févr, vol.157, issue.2, pp.376-83, 2020. ,
High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy, Circulation. 1 juill, vol.76, issue.1, pp.135-176, 1987. ,
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension, Circulation. 14 juin, vol.111, issue.23, pp.3105-3116, 2005. ,
The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension, N Engl J Med. 9 juill, vol.327, issue.2, pp.76-81, 1992. ,
A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension, Eur Respir J. mars, vol.27, issue.3, pp.578-84, 2006. ,
,
, Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT, Circulation. 28 juin, vol.123, issue.25, pp.2985-93, 2011.
,
, Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA), Circulation. 7 janv, vol.129, issue.1, pp.57-65, 2014.
Letter by Bertoletti et al regarding article, « Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA) ». Circulation. 16 sept, vol.130, p.108, 2014. ,
Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL), Circulation. 22 déc, vol.132, issue.25, pp.2403-2414, 2015. ,
Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?, Circ Cardiovasc Qual Outcomes, vol.11, issue.9, p.4757, 2018. ,
Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension, Eur Respir J, vol.53, issue.1, 2019. ,
Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era, Circulation. 13 juill, vol.122, issue.2, pp.156-63, 2010. ,
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension, Eur Respir J. sept, vol.36, issue.3, pp.549-55, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00929872
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation, Eur Respir J. mai, vol.35, issue.5, pp.1079-87, 2010. ,
Validation of the pulmonary hypertension connection equation for survival prediction in pulmonary arterial hypertension, Chest. mars, vol.141, issue.3, pp.642-50, 2012. ,
Predicting survival in pulmonary arterial hypertension in the UK, Eur Respir J. sept, vol.40, issue.3, pp.604-615, 2012. ,
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL), Circulation. 13 juill, vol.122, issue.2, pp.164-72, 2010. ,
The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension, Chest. févr, vol.141, issue.2, pp.354-62, 2012. ,
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies, Chest, vol.156, issue.2, pp.323-360, 2019. ,
Assessing risk in pulmonary arterial hypertension: what we know, what we don't, Eur Respir J, vol.50, issue.2, 2017. ,
REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival, J Heart Lung Transplant, vol.37, issue.4, pp.513-522, 2018. ,
Validation of two predictive models for survival in pulmonary arterial hypertension, Eur Respir J. juill, vol.46, issue.1, pp.152-64, 2015. ,
A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension, Eur Heart J, vol.14, issue.47, pp.4175-81, 2018. ,
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model, Eur Respir J, vol.50, issue.2, 2017. ,
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography, J Am Soc Echocardiogr. juill, vol.23, issue.7, pp.685-713, 2010. ,
Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound, J Am Coll Cardiol. août, vol.6, issue.2, pp.359-65, 1985. ,
Continuous wave Doppler determination of right ventricular pressure: a simultaneous Dopplercatheterization study in 127 patients, J Am Coll Cardiol, vol.6, issue.4, pp.750-756, 1985. ,
Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension, Am J Respir Crit Care Med. 1 avr, vol.179, issue.7, pp.615-636, 2009. ,
Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population, J Am Heart Assoc. 21 août, vol.3, issue.4, 2014. ,
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group, Circulation. 18 mars, vol.95, issue.6, pp.1479-86, 1997. ,
Stepping away from ritual right heart catheterization into the era of noninvasively measured pulmonary artery pressure, J Am Soc Echocardiogr. juill, vol.22, issue.7, pp.820-822, 2009. ,
A simple method for noninvasive estimation of pulmonary vascular resistance, J Am Coll Cardiol. 19 mars, vol.41, issue.6, pp.1021-1028, 2003. ,
A novel non-invasive method of estimating pulmonary vascular resistance in patients with pulmonary arterial hypertension, J Am Soc Echocardiogr. mai, vol.22, issue.5, pp.523-532, 2009. ,
Follow-Up of Pulmonary Hypertension With Echocardiography, JACC Cardiovasc Imaging, vol.9, issue.6, pp.733-779, 2016. ,
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), Eur Heart J. oct, vol.30, issue.20, pp.2493-537, 2009. ,
Tricuspid annular displacement predicts survival in pulmonary hypertension, Am J Respir Crit Care Med, vol.174, issue.9, pp.1034-1075, 2006. ,
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension, J Am Coll Cardiol. 3 avr, vol.39, issue.7, pp.1214-1223, 2002. ,
Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension, Circulation. août, vol.80, issue.2, pp.353-60, 1989. ,
New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension, Eur J Echocardiogr. juill, vol.11, issue.6, pp.516-538, 2010. ,
Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension, J Rheumatol, vol.38, issue.11, pp.2410-2418, 2011. ,
Risk classification of pulmonary arterial hypertension by echocardiographic combined assessment of pulmonary vascular resistance and right ventricular function. Heart Vessels, vol.34, pp.1789-800, 2019. ,
Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension, Am J Cardiol. 1 mai, vol.81, issue.9, pp.1157-61, 1998. ,
Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension, J Cardiol. févr, vol.63, issue.2, pp.149-53, 2014. ,
The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography, Eur Heart J Cardiovasc Imaging. août, vol.13, issue.8, pp.666-72, 2012. ,
Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension, J Am Soc Echocardiogr, vol.15, issue.10, pp.1160-1164, 2002. ,
Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension, Circulation. 22 août, vol.102, issue.8, pp.865-70, 2000. ,
Clinical and prognostic relevance of echocardiographic evaluation of right ventricular geometry in patients with idiopathic pulmonary arterial hypertension, Am J Cardiol. 15 févr, vol.107, issue.4, pp.628-660, 2011. ,
Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension, Circ Cardiovasc Imaging. sept, vol.6, issue.5, pp.711-732, 2013. ,
Right Ventricular Function and Right-Heart Echocardiographic Response to Therapy Predict Longterm Outcome in Patients With Pulmonary Hypertension, Canadian Journal of Cardiology. 1 avr, vol.31, issue.4, pp.529-565, 2015. ,
Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension, Chest. juin, vol.139, issue.6, pp.1299-309, 2011. ,
Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension, Circ Cardiovasc Imaging. 1 sept, vol.5, issue.5, pp.628-664, 2012. ,
Diagnostic and prognostic value of right ventricular strain in patients with pulmonary arterial hypertension and relatively preserved functional capacity studied with echocardiography and magnetic resonance, Int J Cardiovasc Imaging. janv, vol.33, issue.1, pp.39-46, 2017. ,
Relative Importance of Baseline and Longitudinal Evaluation in the Follow-Up of Vasodilator Therapy in Pulmonary Arterial Hypertension, JACC Cardiovasc Imaging, vol.12, issue.11, pp.2103-2114, 2019. ,
Right atrial strain is predictive of clinical outcomes and invasive hemodynamic data in group 1 pulmonary arterial hypertension, Int J Cardiovasc Imaging. juin, vol.33, issue.6, pp.847-55, 2017. ,
Impaired left ventricular mechanics in pulmonary arterial hypertension: identification of a cohort at high risk, Circ Heart Fail. juill, vol.6, issue.4, pp.748-55, 2013. ,
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension, J Am Coll Cardiol. 16 avr, vol.41, issue.8, pp.1380-1386, 2003. ,
Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study), Am J Cardiol. 1 déc, vol.112, issue.11, pp.1834-1843, 2013. ,
Prognostic value of echocardiographic changes in patients with pulmonary arterial hypertension receiving parenteral prostacyclin therapy, J Am Soc Echocardiogr. juill, vol.27, issue.7, pp.733-741, 2014. ,
,
, Echocardiographic Assessment of Right Ventricular Function and Response to Therapy in Pulmonary Arterial Hypertension, Am J Cardiol, vol.124, issue.8, pp.1298-304, 2019.
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension, J Heart Lung Transplant, 2017. ,
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension, Eur Respir J. août, vol.50, issue.2, p.1700889, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01757586
Prognostic importance of Kidney, Heart and Interstitial lung diseases (KHI triad) in PH: A machine learning study, Arch Cardiovasc Dis. 1 sept, 2020. ,
Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy, J Am Coll Cardiol. 6 déc, vol.58, issue.24, pp.2511-2520, 2011. ,
Signs of Right Ventricular Deterioration in Clinically Stable Patients With Pulmonary Arterial Hypertension, Chest. 1 avr, vol.147, issue.4, pp.1063-71, 2015. ,
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr. avr, vol.29, issue.4, pp.277-314, 2016. ,
Prognostic value of left ventricular reverse remodeling and performance improvement after cardiac resynchronization therapy: A prospective study, International Journal of Cardiology. 1 févr, vol.204, pp.6-11, 2016. ,
Left Ventricular Reverse Remodeling but Not Clinical Improvement Predicts Long-Term Survival After Cardiac Resynchronization Therapy, Circulation. 13 sept, vol.112, issue.11, pp.1580-1586, 2005. ,
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension, Eur Respir J. sept, vol.36, issue.3, pp.549-55, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00929872
An overview of the 6th World Symposium on Pulmonary Hypertension, Eur Respir J. janv, vol.53, issue.1, 2019. ,
Follow-up tricuspid annular plane systolic excursion predicts survival in pulmonary arterial hypertension: Pulmonary Circulation, pp.13-2017 ,
,
Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension, Am J Cardiol. 1 janv, vol.111, issue.1, pp.143-151, 2013. ,
A metaanalysis of randomized controlled trials in pulmonary arterial hypertension, Eur Heart J. févr, vol.30, issue.4, pp.394-403, 2009. ,
The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance, J Am Soc Echocardiogr. mai, vol.17, issue.5, pp.443-450, 2004. ,
Assessment of right ventricular function using two-dimensional echocardiography, Am Heart J. mars, vol.107, issue.3, pp.526-557, 1984. ,